Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

Nature Medicine

Volumn 1, Issue 11, 1995, Pages 1167-1173

  Gallimore, Awen ^a   Cranage, Martin ^b   Cook, Nicola ^b   Almond, Neil ^c   Bootman, Janet ^c   Ruo, Erling ^d   Silvera, Pete ^c   Dennis, Michael ^b   Corcoran, Terry ^b   Stott, Jim ^c   McMichael, Andrew ^a   Gotch, Frances ^a,e  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^d LAB CENTRE FOR DISEASE CONTROL   (Canada)

^e INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GAMMA INTERFERON; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

ANIMAL; CELLS, CULTURED; DNA, VIRAL; GENE PRODUCTS, GAG; GENE PRODUCTS, NEF; LEUKOCYTES, MONONUCLEAR; MACACA FASCICULARIS; POLYMERASE CHAIN REACTION; PROVIRUSES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIV; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES; VIREMIA; VIRUS REPLICATION;

EID: 0028866238     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1195-1167     Document Type: Article

References (40)

1. Bangham, C.R.M. & McMichael, A.J. in TCells (eds Feldmann, M., Lamb, J. & Owen, M.J.) 281-310 (Wiley, New York, 1989).
2. Lukacher, A.E., Braciale, V.L. & Braciale, TJ. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. exp. Med. 160, 814-826 (1984).
3. McMichael, A.J. & Walker, B. Cytotoxic T lymphocyte epitopes: Implications for HIV vaccines. AIDS (suppl.) 8, S155-S173 (1994).
4. Koup, R. et al. Temporal association of cellular immune responses with the initial control of viraemia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650-4655 (1994).
5. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563-1566 (1986).
6. Tsubota, H.C., Lord, CL, Watkins, D.I., Morimoto, C. & Letvin, NX. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J. exp. Med. 169, 1421-1434 (1989).
7. + cell anti-HIV activity correlates with the clinical state of the infected individual. J. clin. Invest. 87, 1462-1466(1991).
8. + lymphocytes. J. Immun. 140, 2237-2242 (1988).
9. Rowland-Jones, S. et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1, 59-64 (1995).
10. Chakrabarti, L. et al. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature 328, 543-547 (1987).
11. Letvin, N. et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-1II. Science 230, 71-73 (1985).
12. Kestler, H. et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662 (1991).
13. Rud, E. et al. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J. Gen. Virol. 75, 529-543 (1994).
14. Rud, E. et al. Infectious molecular clones of SIVmac32H: Nef deletion controls ability to re-isolate virus from rhesus macaques. Vaccines 92: Modem Approaches to New Vaccines including AIDS (eds F.Brown, R.M.Chanock, H.S.Ginsberg, and R.A.Lerner) 239-245 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1992).
15. Daniel, M.D., Kirchhoff, F., Czajak, S.C., Sehgal, P.K. & Desrosiers, R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941 (1992).
16. Robert-Guroff, M. et al. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J. Virol. 64, 3391-3398 (1990).
17. Bachmann, M.-F. et al. Induction of protective cytotoxic T cells with viral proteins. Eur. J. Immun. 24, 2228-2236 (1994).
18. Cao, Y., Qin, L., Zhang, L., Safrit, J. & Ho, D. Virologic and immunologic characterisation of long-term survivors of human immunodeficiency virus type 1 infection. New Engl J. Med. 332, 201-208 (1995).
19. Pantaleo, G. et al. Studies in subjects with Long-term nonprogressive human immunodeficiency virus infection. New Eng. J. Med. 332, 209-216 (1995).
20. Ariyoshi, K. et al. HIV-2-specific cytoxic T-lymphocyte activity is inversely related to proviral load. AIDS 9, 555-559 (1995).
21. Yasutomi, Y., Reimann, K.A., Lord, C.I., Miller, M.D. & Letvin, N.L. Simian immunodeficiency virus-specific CD8’ lymphocyte response in acutely infected rhesus monkeys. J. Virol 67, 1707-1711 (1993).
22. + T cells: Evidence for a soluble inhibitor. J. Immun. 144, 2961-2966 (1990).
23. Gotch, F.M., Nixon, D.F., Alp, N., McMichael, A.J. & Borysiewicz, L.K. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int. Immun. 2, 707-712 (1990).
24. Abímuku, A.G. et al. HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques. Nature Med. 1, 321-329 (1995).
25. Culmann, B., Gomard, E. & Kieny, M.-P. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 nef protein. J. Immun. 146, 1560’1565 (1991).
26. Culmann-Penciolelli, B. et al. Identification of multirestricted immunodominant regions recognised by cytolytic T lymphocytes in the human immunodeficiency virus type 1 nef protein. J. Virol 68, 7336-7343 (1994).
27. Bourgault, I. et al. Simian immunodeficiency virus as a model for vaccination against HIV. J. Immun. 152, 2530-2537 (1994).
28. Lamhamedi-Cherradi, S.C. et al. Qualitative and quantitative analysis of human cytotoxic T lymphocyte responses to HIV-1 proteins. AIDS 6, 1249-1258 (1992).
29. Nowak, M.A. et al. Antigenic oscillations and shifting immunodominance in HïV-1 infections. Nature (in the press).
30. Rowland-Jones, S. & McMichael, A.J. Cell-mediated immune responses in HlV-ex-posed individuals: Have they cleared the virus? Curr. Topics Immun. (in the press).
31. Gotch, F., Hovell, R., Delchambre, M., Silvera, P. & McMichael, M. Cytotoxic T-cell responses to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus. AIDS 5, 317-320 (1991).
32. Townsend, A. et al. Defective presentation to class 1 restricted cytotoxic T lymphocytes in vaccinia infected cells is overcome by enhanced degradation of antigen. J. exp. Med. 168, 1211-1224 (1988).
33. Norusis, MJ. SPSS/PC+ V2.0 (SPSS Inc., Chicago, Illinois, 1988).
34. Lefkovits, I. & Waldmann, H. Limiting dilution analysis of cells in the immune system (Cambridge University Press, Cambridge, 1979).
35. Rose, J., Silvera, P., Flanagan, B., Kitchin, P. & Almond, N. The development of PCR-based assays for the detection and differentiation of simian immunodeficiency virus in vivo. J. Virol Methods 51, 229-239 (1995).
36. Bootman, J. & Kitchin, P. An international collaborative study to assess a set of reference reagents for HIV-l PCR. J. Virol Methods 37, 23-42 (1992).
37. Sambrook, J., Fritsch, E. & Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd edn (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989).
38. Saluz, H. & Jost, J. A simple high-resolution procedure to study DNA methylation and in vivo DNA-protein interactions on a single copy gene level in higher eukaryotes. Proc. natn. Acad. Sci. U.SA. 86, 2602-2626 (1989).
39. An, S., Franklin, D. & Fleming, K. Generation of dioxygenin-labelled doublestranded probes using the polymerase chain reaction. Molec. Cell Probes 6, 193-200 (1992).
40. Bootman, J.S. & Kitchen, PA Reference preparations in the standardisation of HIV. 1 PCR: An international collaborative study. J. Vrnl. Methods49, 1-8 (1994).